Elevated ALT levels in those who subsequently develop T2DM may indicate the existence of a condition called non-alcoholic fatty liver disease (NAFLD), a disorder closely associated with metabolic syndrome and insulin resistance. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.